Drugs Made In America Acquisition Corp.
|
Dec-25 |
Dec-24 |
| Total revenue |
0.00 |
|
| Selling, general and administrative |
0.00 |
0.00 |
| Research and development |
|
|
| Other operating expenses |
0.00 |
0.00 |
| Operating income |
0.00 |
0.00 |
| Non-operating income (net) |
0.01 |
0.00 |
| Income before tax |
0.01 |
0.00 |
| Net income |
0.01 |
0.00 |
Show Quarterly Income Statement
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
| Total revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
| Selling, general and administrative |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Research and development |
|
|
|
|
|
|
|
|
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Non-operating income (net) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net income |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Dec-25 |
Dec-24 |
| Cash and cash equivalents |
0.00 |
0.00 |
| Short-term investments |
|
0.00 |
| Other current assets |
0.00 |
0.00 |
| Total current assets |
0.00 |
0.00 |
| Property, plant and equipment, net |
|
|
| Goodwill |
|
|
| Intangible assets |
|
|
| Long-term investments |
|
|
| Other non-current assets |
|
|
| Total assets |
0.24 |
0.00 |
|
| Accounts payable |
0.00 |
0.00 |
| Short-term debt |
|
0.00 |
| Current portion of long-term debt |
|
0.00 |
| Deferred revenue |
|
|
| Other current liabilities |
0.00 |
0.00 |
| Long-term debt |
|
|
| Capital lease obligations |
|
|
| Other non-current liabilities |
|
|
| Total liabilities |
0.01 |
0.00 |
|
| Common stock and paid-in capital |
0.24 |
0.00 |
| Retained earnings |
-0.01 |
0.00 |
| Common shares outstanding |
21 |
9 |
Show Quarterly Balance Sheet
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
| Cash and cash equivalents |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Short-term investments |
|
|
|
|
|
0.00 |
|
|
| Other current assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
| Total current assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
| Total assets |
0.24 |
0.24 |
0.24 |
0.24 |
0.23 |
0.00 |
0.00 |
0.00 |
|
| Accounts payable |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
| Short-term debt |
0.00 |
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
| Current portion of long-term debt |
0.00 |
|
|
|
0.00 |
|
0.00 |
0.00 |
| Deferred revenue |
|
|
|
|
|
|
|
|
| Other current liabilities |
0.00 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Long-term debt |
|
|
|
|
|
|
|
|
| Capital lease obligations |
|
|
|
|
|
|
|
|
| Other non-current liabilities |
|
|
|
|
|
|
|
|
| Total liabilities |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
|
| Common stock and paid-in capital |
0.24 |
0.24 |
0.24 |
0.23 |
0.23 |
0.00 |
0.00 |
0.00 |
| Retained earnings |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
| Common shares outstanding |
23 |
34 |
23 |
34 |
26 |
9 |
9 |
9 |
|
Dec-25 |
Dec-24 |
| Net income |
|
|
| Depreciation, depletion and amortization |
|
|
| Stock-based compensation |
|
|
| Change in inventory |
|
|
| Other working capital changes |
0.00 |
0.00 |
| Capital expenditures |
0.00 |
0.00 |
| Others incl. marketable securities changes |
-0.23 |
0.00 |
| Dividend payout |
|
|
| Common stock repurchases |
|
|
| Net Debt Issuance |
0.23 |
0.00 |
|
| Change in cash |
0.00 |
0.00 |
Show Quarterly Cash Flow
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
| Net income |
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
|
|
|
|
|
|
|
|
| Stock-based compensation |
|
|
|
|
|
|
|
|
| Change in inventory |
|
|
|
|
|
|
|
|
| Other working capital changes |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.00 |
0.00 |
0.23 |
-0.23 |
-0.23 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
|
|
|
|
| Net Debt Issuance |
0.00 |
0.00 |
-0.23 |
0.23 |
0.23 |
0.00 |
0.00 |
0.00 |
|
| Change in cash |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Drugs Made In America Acquisition Corp. (DMAA) - Depreciation And Amortization
Drugs Made In America Acquisition Corp. (DMAA) - Net Income
Drugs Made In America Acquisition Corp. (DMAA) - Ebitda
Drugs Made In America Acquisition Corp. (DMAA) - Net Income From Continuing Operations
Drugs Made In America Acquisition Corp. (DMAA) - Income Before Tax
Drugs Made In America Acquisition Corp. (DMAA) - Interest Income
Drugs Made In America Acquisition Corp. (DMAA) - Net Interest Income
Drugs Made In America Acquisition Corp. (DMAA) - Operating Expenses
Drugs Made In America Acquisition Corp. (DMAA) - Selling General And Administrative
Drugs Made In America Acquisition Corp. (DMAA) - Operating Income